PleuraSeal Pivotal Study (US)

PHASE3TerminatedINTERVENTIONAL
Enrollment

230

Participants

Timeline

Start Date

August 31, 2008

Primary Completion Date

September 30, 2010

Study Completion Date

April 30, 2011

Conditions
Open Thoracotomy
Interventions
DEVICE

PleuraSeal Sealant System

Lung Sealant Device + standard tissue closing techniques (sutures/staples)

PROCEDURE

Standard Tissue Closure Techniques

Standard tissue closure techniques (sutures/ staples) alone

Trial Locations (1)

01730

Confluent Surgical, Bedford

All Listed Sponsors
lead

Integra LifeSciences Corporation

INDUSTRY

NCT00748124 - PleuraSeal Pivotal Study (US) | Biotech Hunter | Biotech Hunter